SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-19-003763
Filing Date
2019-06-03
Accepted
2019-06-03 08:30:43
Documents
19
Period of Report
2019-06-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_060319.htm 8-K 28055
2 EXHIBIT 99.1 exh_991.htm EX-99.1 20507
3 GRAPHIC exh991_01.jpg GRAPHIC 196393
4 GRAPHIC exh991_02.jpg GRAPHIC 198898
5 GRAPHIC exh991_03.jpg GRAPHIC 205145
6 GRAPHIC exh991_04.jpg GRAPHIC 194588
7 GRAPHIC exh991_05.jpg GRAPHIC 178974
8 GRAPHIC exh991_06.jpg GRAPHIC 147010
9 GRAPHIC exh991_07.jpg GRAPHIC 195867
10 GRAPHIC exh991_08.jpg GRAPHIC 194071
11 GRAPHIC exh991_09.jpg GRAPHIC 198590
12 GRAPHIC exh991_10.jpg GRAPHIC 173692
13 GRAPHIC exh991_11.jpg GRAPHIC 180067
14 GRAPHIC exh991_12.jpg GRAPHIC 160845
15 GRAPHIC exh991_13.jpg GRAPHIC 204550
16 GRAPHIC exh991_14.jpg GRAPHIC 182904
17 GRAPHIC exh991_15.jpg GRAPHIC 184747
18 GRAPHIC exh991_16.jpg GRAPHIC 178820
19 GRAPHIC exh991_17.jpg GRAPHIC 132619
  Complete submission text file 0001171843-19-003763.txt   4328330
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 19872214
SIC: 2834 Pharmaceutical Preparations